Research / Humanin

Humanin

Neuroprotective & Cognitive

← Back to Shop
Humanin

Humanin Research Information

Mitochondrial-Derived Peptide

24-Amino Acid Cytoprotective Peptide for Neurobiology Research

Important: This information is for educational and research purposes only. Always consult with a qualified healthcare professional before use.

What is Humanin?

Humanin (HN) is a 24-amino acid mitochondrial-derived peptide (MDP) discovered in 2001, encoded within the 16S ribosomal RNA gene of mitochondrial DNA. It possesses anti-oxidant, anti-inflammatory, and anti-apoptotic properties and is localized to the mitochondria.

Humanin is the first identified peptide encoded by mitochondrial DNA that is biologically active, opening a new field of mitochondrial-derived peptides (MDPs).

Mechanism of Action

Humanin functions through multiple pathways to support research models:

Receptor Binding

Binds to FPRL1 and FPRL2 receptors to activate cytoprotective pathways

Autophagy Induction

Acts as an autophagy inducer, promoting cell survival under metabolic and oxidative stress

Apoptosis Inhibition

Inhibits apoptosis and reduces oxidative stress through anti-inflammatory pathways

Humanin protects neurons from amyloid beta toxicity and regulates systemic metabolism.

Research Applications

Neuroprotection

Alzheimer's disease models, neuronal survival studies

Mitochondrial Research

Mitochondrial-derived peptide signaling, cellular energy metabolism

Metabolic Research

Insulin resistance, lipid metabolism, glucose regulation

Cancer Research

Prostate cancer studies, tumor suppressor mechanisms

Clinical Studies

Key Research Findings:

  • Humanin significantly downregulated in prostate cancer and precancerous lesions
  • Decreased serum levels in PCOS, associated with androgen excess and insulin resistance
  • Demonstrated neuroprotective effects in Alzheimer's disease models
  • Functions as a cytoprotective peptide through mitochondrial pathways

Dosing Guide

Reconstitute 10mg vial with 3mL bacteriostatic water = 3.33 mg/mL concentration. Units assume a standard U-100 insulin syringe (100 units = 1 mL).

Step 1: Select Vial Size

Step 2: Select Dose

Research protocols typically range from 1-5 mg daily via subcutaneous injection.

Vial Size

10mg Vial

Selected Dose

1 mg

Doses per Vial

10 doses

Units on Syringe

30 units

Volume

0.30 mL

Protocol

Starting

Recommended Schedule

Once daily - Subcutaneous Injection

Do not change your dose unless advised by a qualified professional.

Reconstitution Instructions

Add 3mL of bacteriostatic water to your freeze-dried vial and mix gently. After reconstitution, use the table below to draw your dose:

Vial Size

10mg vial with 3mL bac water (3.33 mg/mL)

DoseUnits on SyringeVolume (mL)Protocol

Always use a new sterile needle and syringe for each injection.

Safety & Precautions

Do not use if you:

  • Are allergic to Humanin or any components
  • Are pregnant or breastfeeding

Warning: If you experience severe allergic reactions, difficulty breathing, or signs of anaphylaxis, seek immediate medical help.

References

  • Hashimoto Y, et al. A rescue factor abolishing neuronal cell death. Biochem Biophys Res Commun. 2001
  • Yen K, et al. The emerging role of the mitochondrial-derived peptide humanin. J Mol Endocrinol. 2013

This information is for educational and research purposes only. Always consult with a qualified healthcare professional.

Last updated: August 2026

⚠️ FOR RESEARCH PURPOSES ONLY